PROX1 and gastric cancer: Furthermore, a comprehensive genomics-based bioinformatics analysis study that included 375 cases with OS data for GC patients also supports our viewpoint and confirms that expression of PROX1 is not associated with OS at 1-year, 3-years, and 5-year.